Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Jun;53(6):835–838. doi: 10.1038/bjc.1986.141

Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug.

J Cummings, C S McArdle
PMCID: PMC2001410  PMID: 3718837

Full text

PDF
835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chan K. K., Cohen J. L., Gross J. F., Himmelstein K. J., Bateman J. R., Tsu-Lee Y., Marlis A. S. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep. 1978 Aug;62(8):1161–1171. [PubMed] [Google Scholar]
  2. Cummings J., Merry S., Willmott N. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). Eur J Cancer Clin Oncol. 1986 Apr;22(4):451–460. doi: 10.1016/0277-5379(86)90112-4. [DOI] [PubMed] [Google Scholar]
  3. Cummings J. Method for the determination of 4'-deoxydoxorubicin, 4'-deoxydoxorubicinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography. J Chromatogr. 1985 Jun 14;341(2):401–409. doi: 10.1016/s0378-4347(00)84053-0. [DOI] [PubMed] [Google Scholar]
  4. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta. 1973 Oct 25;323(3):466–483. doi: 10.1016/0005-2736(73)90191-0. [DOI] [PubMed] [Google Scholar]
  5. Gottlieb J. A., Rivkin S. E., Spigel S. C., Hoogstraten B., O'Bryan R. M., Delaney F. C., Singhakowinta A. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study. Cancer. 1974 Feb;33(2):519–526. doi: 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  6. Harris P. A., Gross J. F. Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemother Rep. 1975 Jul-Aug;59(4):819–825. [PubMed] [Google Scholar]
  7. Moertel C. G. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol. 1976 Sep;5(3):777–793. [PubMed] [Google Scholar]
  8. Moertel C. G. Clinical management of advanced gastrointestinal cancer. Cancer. 1975 Aug;36(2):675–682. doi: 10.1002/1097-0142(197508)36:2+<675::aid-cncr2820360810>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  9. Ozols R. F., Locker G. Y., Doroshow J. H., Grotzinger K. R., Myers C. E., Young R. C. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res. 1979 Aug;39(8):3209–3214. [PubMed] [Google Scholar]
  10. Schwartz H. S. A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem Med. 1973 Jun;7(3):396–404. doi: 10.1016/0006-2944(73)90060-4. [DOI] [PubMed] [Google Scholar]
  11. Terasaki T., Iga T., Sugiyama Y., Hanano M. Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. J Pharm Sci. 1984 Oct;73(10):1359–1363. doi: 10.1002/jps.2600731008. [DOI] [PubMed] [Google Scholar]
  12. Yesair D. W., Schwartzbach E., Shuck D., Denine E. P., Asbell M. A. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. Cancer Res. 1972 Jun;32(6):1177–1183. [PubMed] [Google Scholar]
  13. Yesair D. W., Thayer P. S., McNitt S., Teague K. Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo. Eur J Cancer. 1980 Jul;16(7):901–907. doi: 10.1016/0014-2964(80)90328-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES